In gynecology, AMR poses significant challenges due to the prevalence of infections like urinary tract infections (UTIs), bacterial vaginosis, and pelvic inflammatory disease (PID). These conditions often require antimicrobial therapy, and the emergence of resistant strains makes treatment more difficult, leading to prolonged illness, increased healthcare costs, and higher morbidity.
